Mitochondria are the crucial regulators for major source of ATP for different cellular events. Due to damage episodes, mitochondria have been established for plethora of an alarming signals of stress that leads to cellular deterioration and thereby causing programmed cell death. Defects in mitochondria plays a key role in arbitrating pathophysiological machinery with recent evince delineating a constructive role in mitophagy mediated mitochondrial injury. Mitophagy have been known for eradication of damaged mitochondria via autophagy process. Mitophagy has been investigated as an evolutionarily conserved mechanism for mitochondrial quality control and homeostasis. Impaired mitophagy has been critically linked with pathogenesis of inflammatory diseases. Nevertheless, the exact mechanism is not quite revealed, and it is still debatable. The purpose of this review was to enquire the possible role of mitophagy and its associated mechanism in inflammation mediated diseases at both cellular and molecular level.
In the present study we have investigated the effect of conditioned media (CM) collected from the cancer cell lines (K562, MCF-7, and HeLa) on Peripheral blood mononuclear cells (PBMCs) isolated from the healthy human blood. The soluble factors in the CM are probably responsible for the differential mRNA expression of Foxp3, Helios, Neuropilin-1 (NRP-1) and Glycoprotein A repetitions predominant (GARP) along with IFNγ and TGF-β in PBMCs cultured with cancer cells CM. The PBMCs cultured with CM of K562 showed increased expression of Foxp3, Helios, NRP-1, GARP, IFNγ and TGF-β compared to PBMCs cultured with MCF-7 and HeLa cells. In addition, the intracellular staining on PBMCs cultured with CM from cell lines were also evaluated for CD4, CD25, Foxp3, Helios and NRP-1 by multicolor flow cytometry. The expression of CD4+CD25+Foxp3+, CD4+Helios+Foxp3+ and CD+NRP-1+Foxp3+ showed retarded cell population as compared to control PBMCs. Our data suggest data suggest that soluble factors in CM of cancer cells may trigger the immune response in PBMCs resulting in a systematic response. Further research could enable to identify the specific soluble factors that are involved in trafficking of cells into the immune cascades, which might be a potentially safe and promising strategy for targeting human cancers.
Chronic inflammation in the large intestinal epithelial to rectum is a major risk for malignancies. The pathogenesis of colitis associated cancer is distinct with perilous molecular mechanism. The inflammation leads to damage of cells resulting in symptomatic conditions including cancer. This suggest the relationship between certain cancer due to its associated factors such as environment, genetics, and chronic inflammation leading to cancer. Colorectal cancer (CRC) has also been acknowledged as bowel, rectal, or colon cancer. The most common types of adenocarcinomas are associated with colorectal cancer. The lymphomas, carcinoids, sarcoma, and gastrointestinal tumors are also associated with CRC. Most disorders with chronic inflammation and exposure of immunosuppressant have an increased risk with the development of cancer leading towards the treatment of cancer by various therapies like radiation therapy, chemotherapy, hormonal therapy, further into immunotherapy, and targeted therapy. The prognosis of CRC has always been controversial.